학술논문

Prospective, Open-Label Study Evaluating the Safety and Tolerability of Higher Infusion Rates of Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Interim analyses.
Document Type
Journal
Source
NEUROLOGY; APR 9 2019, 92 15, 3p. Supplement: S
Subject
Language
English
ISSN
1526632X